Latest & greatest articles for covid-19

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on covid-19 or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on covid-19 and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for covid-19

41. COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol

COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Coronavirus guidance is being updated (...) . Read Stay alert. Control the virus. Save lives. Guidance COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol COVID-19 guidance for commissioners and service providers for those dependent on drugs or alcohol Published 15 April 2020 Last updated 15 May 2020 — From: and Documents HTML Details This guidance outlines COVID-19 advice for commissioners and service providers involved in assisting people who are dependent on drugs or alcohol or both. Please

2021 Public Health England

42. COVID-19: guidance for stepdown of infection control precautions and discharging patients to home settings

COVID-19: guidance for stepdown of infection control precautions and discharging patients to home settings COVID-19: guidance for stepdown of infection control precautions within hospitals and discharging COVID-19 patients from hospital to home settings - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any (...) time. Hide Search Stay at home Only go outside for food, health reasons or work (but only if you cannot work from home) If you go out, stay 2 metres (6ft) away from other people at all times Wash your hands as soon as you get home Do not meet others, even friends or family. You can spread the virus even if you don’t have symptoms. Guidance COVID-19: guidance for stepdown of infection control precautions within hospitals and discharging COVID-19 patients from hospital to home settings Advice

2021 Public Health England

43. Coronavirus (COVID-19): admission and care of people in care homes

Coronavirus (COVID-19): admission and care of people in care homes Coronavirus (COVID-19): admission and care of people in care homes - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Stay at home Only go outside for food, health reasons or work (but only if you cannot work from home (...) ) If you go out, stay 2 metres (6ft) away from other people at all times Wash your hands as soon as you get home Do not meet others, even friends or family. You can spread the virus even if you don’t have symptoms. Guidance Coronavirus (COVID-19): admission and care of people in care homes How to protect care home residents and staff during the coronavirus outbreak. Published 2 April 2020 From: , , , and Documents Explore the topic Topical events Is this page useful? Thank you for your feedback Help us

2021 Public Health England

44. COVID-19: guidance for sampling and for diagnostic laboratories

COVID-19: guidance for sampling and for diagnostic laboratories Wuhan novel coronavirus: guidance for clinical diagnostic laboratories - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Wuhan novel coronavirus: guidance for clinical diagnostic laboratories Information for clinical (...) diagnostic laboratories on specimens associated with Wuhan novel coronavirus. Published 15 January 2020 Last updated 17 January 2020 — From: Documents HTML HTML If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Details These documents provide guidance to clinical diagnostic laboratories on the handling and processing

2021 Public Health England

45. COVID-19: vaccine surveillance strategy

COVID-19: vaccine surveillance strategy COVID-19: vaccine surveillance strategy - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Show or hide search Search on GOV.UK Search Menu National lockdown: stay at home Check how the new rules affect you Guidance COVID-19: vaccine surveillance strategy (...) Information on the COVID-19 vaccine surveillance strategy in England. Published 11 January 2021 From: Documents Ref: PHE gateway number GW-1763 PDF , 564KB , 22 pages This file may not be suitable for users of assistive technology. Request an accessible format. If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Details

2021 Public Health England

46. COVID-19: enhanced surveillance of cases in vaccinated individuals

COVID-19: enhanced surveillance of cases in vaccinated individuals COVID-19: enhanced surveillance of cases in vaccinated individuals - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Show or hide search Search on GOV.UK Search Menu National lockdown: stay at home Check how the new rules affect (...) you Guidance COVID-19: enhanced surveillance of cases in vaccinated individuals Information on the enhanced surveillance of coronavirus (COVID-19) cases in vaccinated individuals. Published 14 January 2021 From: Documents HTML PDF , 676KB , 1 page This file may not be suitable for users of assistive technology. Request an accessible format. If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what

2021 Public Health England

47. National protocol for COVID-19 Vaccine AstraZeneca (ChAdOx1-S [recombinant])

National protocol for COVID-19 Vaccine AstraZeneca (ChAdOx1-S [recombinant]) National protocol for COVID-19 Vaccine AstraZeneca (ChAdOx1-S [recombinant]) - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Show or hide search Search on GOV.UK Search Menu National lockdown: stay at home Check how (...) the new rules affect you Guidance National protocol for COVID-19 Vaccine AstraZeneca (ChAdOx1-S [recombinant]) This protocol is for the administration of COVID-19 Vaccine AstraZeneca (ChAdOx1-S [recombinant]) to individuals in accordance with the national COVID-19 vaccination programme. Published 10 January 2021 From: Documents Ref: PHE gateway number GW-1853 MS Word Document , 140KB This file may not be suitable for users of assistive technology. Request an accessible format. If you use assistive

2021 Public Health England

48. Living Rapid Review Update 14: What is the specific role of daycares and schools in COVID-19 transmission?

Living Rapid Review Update 14: What is the specific role of daycares and schools in COVID-19 transmission? Living Rapid Review Update 11: What is the specific role of daycares and schools in COVID-19 transmission? | Covid-19 Rapid Review | National Collaborating Centre for Methods and Tools This browser does not support PDFs, or the PDF is too large to render. Please download the PDF:

2021 COVID-19 Rapid Evidence Service

49. National protocol for COVID-19 mRNA vaccine BNT162b2 (Pfizer/BioNTech)

National protocol for COVID-19 mRNA vaccine BNT162b2 (Pfizer/BioNTech) National protocol for COVID-19 mRNA vaccine BNT162b2 (Pfizer/BioNTech) - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Show or hide search Search on GOV.UK Search Menu National lockdown: stay at home Check how the new rules (...) affect you Guidance National protocol for COVID-19 mRNA vaccine BNT162b2 (Pfizer/BioNTech) This protocol is for the administration of COVID-19 mRNA vaccine BNT162b2 to individuals in accordance with the national COVID-19 vaccination programme. Published 18 December 2020 Last updated 10 January 2021 — From: Documents Ref: PHE gateway number GW-1861 MS Word Document , 142KB This file may not be suitable for users of assistive technology. Request an accessible format. If you use assistive technology

2021 Public Health England

50. Protective measures for groups vulnerable to COVID-19

Protective measures for groups vulnerable to COVID-19 Rapid review of public health guidance on protective measures for vulnerable groups Health Information and Quality Authority Page 1 of 88 Rapid review of public health guidance on protective measures for vulnerable groups in the context of COVID-19 Updated on: 4 March 2021 Rapid review of public health guidance on protective measures for vulnerable groups Health Information and Quality Authority Page 2 of 88 Version history Version Date (...) for vulnerable groups Health Information and Quality Authority Page 9 of 88 Key points ? A variety of protective measures are being taken to protect vulnerable groups who are at high risk of severe illness from COVID-19 in all countries included in this review. In general, people who are considered vulnerable to more severe illness are those that are of an older age, with chronic conditions if not well-managed or are in receipt of therapies that weaken the immune system. ? Belgium, Canada, Finland, Germany

2021 Health Information and Quality Authority

51. COVID-19: mitigation of risks in occupational settings with a focus on ethnic minority groups

COVID-19: mitigation of risks in occupational settings with a focus on ethnic minority groups COVID-19: mitigation of risks in occupational settings with a focus on ethnic minority groups - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Show or hide search Search on GOV.UK Search Menu Guidance (...) and support Take action now for new rules in 2021 Guidance COVID-19: mitigation of risks in occupational settings with a focus on ethnic minority groups Consensus statement from Public Health England, the Health and Safety Executive and the Faculty of Occupational Medicine. Published 20 November 2020 From: Applies to: England Documents HTML Details Consensus statement from Public Health England (PHE), Health and Safety Executive (HSE ) and the Faculty of Occupational Medicine (FOM) on the mitigation

2021 Public Health England

52. COVID-19: guidance for households with possible coronavirus infection

COVID-19: guidance for households with possible coronavirus infection COVID-19: guidance for households with possible coronavirus infection - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance COVID-19: guidance for households with possible coronavirus infection (...) Stay at home guidance for households with possible coronavirus (COVID-19) infection. Published 12 March 2020 Last updated 20 September 2020 — From: Documents HTML HTML Ref: PHE publications gateway number GW-1342 . Please tell us what format you need. It will help us if you say what assistive technology you use. . Please tell us what format you need. It will help us if you say what assistive technology you use. . Please tell us what format you need. It will help us if you say what assistive

2021 Public Health England

53. Covid-19: Mandatory Vaccination

Covid-19: Mandatory Vaccination COVID-19: MANDATORY VACCINATION An Annotated Bibliography from the Penn Medicine Center for Evidence-based Practice March 2021 Project director: Nikhil K. Mull, MD (CEP) Lead analyst: Matthew D. Mitchell, PhD (CEP) Keywords: COVID-19, vaccine, healthcare workers Summary Mass vaccination is seen as a crucial intervention to control and end the COVID-19 pandemic, especially in the setting of healthcare facilities and congregate residential settings. Safe (...) topic, please contact CEP. © Copyright 2021 by the Trustees of the University of Pennsylvania. All rights reserved. No part of this publication may be reproduced without permission in writing from the Trustees of the University of Pennsylvania. B546 CEP Annotated Bibliography: Mandatory vaccination ©2021 Trustees of the University of Pennsylvania. All rights reserved. 2 Introduction The COVID-19 pandemic has claimed over a million lives worldwide, and has led to economic losses in the trillions

2021 Centre for Evidence-Based Practice, Penn Medicine

54. CTS Information and Guidance for Respiratory Health Care Professionals on COVID 19 Vaccination

- and territory- specific. For the latest detailed vaccination rollout plans, visit this website and go to the vaccine page for your province or territory: https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus- infection/prevention-risks/covid-19-vaccine-treatment/vaccine-rollout.html#a3 NACI recommendations on the use of COVID-19 vaccines 18 (updated recommendations March 29, 2021) NACI recommendations are now worded as “should” (strong) or “may” (discretionary). • A strong (...) CTS Information and Guidance for Respiratory Health Care Professionals on COVID 19 Vaccination V-4.0 APRIL 6, 2021 1 This advice is for health care professionals and we cannot answer individual patient queries. Those looking for further information are advised to speak to their physician, who are best placed to answer specific questions. CTS Information and Guidance for Respiratory Health Care Professionals on COVID 19 Vaccination Introduction This Canadian Thoracic Society (CTS) document aims

2021 Canadian Thoracic Society

55. Public health measures and strategies to limit the spread of COVID-19

Public health measures and strategies to limit the spread of COVID-19 Public health measures and strategies to limit the spread of COVID-19 Health Information and Quality Authority Page 1 of 130 Public health measures and strategies to limit the spread of COVID-19: an international review Update submitted to NPHET: 16 March 2021 Published: 22 March 2021 Public health measures and strategies to limit the spread of COVID-19 Health Information and Quality Authority Page 2 of 130 Version history (...) created with updated public health measures on education only. V6.0 06 January 2021 Updated and provided to NPHET for information. Public health measures and strategies to limit the spread of COVID-19 Health Information and Quality Authority Page 3 of 130 ? Included information on the current epidemiological situation in each country. ? Updated the education public health measures only. V7.0 3 February 2021 Updated and provided to NPHET for information. ? Included updated information on antigen

2021 Health Information and Quality Authority

56. Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong Full Text available with Trip Pro

Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info Close (...) RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation NPJ Digit Med Actions . 2021 Apr 8;4(1):66. doi: 10.1038/s41746-021-00433-4. Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong , , , , , , , , , , , , , Affiliations Expand Affiliations 1 School of Data Science, City University of Hong Kong, Hong Kong, China. 2 Cardiovascular Analytics Group, Laboratory

2021 EvidenceUpdates

57. Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England Full Text available with Trip Pro

Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features (...) are temporarily unavailable. COVID-19 Information Show account info Close Account Logged in as: username Search: Search Save Email Send to Display options Display options Format Save citation to file Format: Create file Cancel Email citation Subject: 1 selected item: 33798464 - PubMed To: Format: MeSH and other data Send email Cancel Add to Collections Create a new collection Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your

2021 EvidenceUpdates

58. Clinical effectiveness of drugs in hospitalized patients with COVID-19: a systematic review and meta-analysis Full Text available with Trip Pro

:110668. doi: 10.1016/j.biopha.2020.110668. Epub 2020 Aug 24. Biomed Pharmacother. 2020. PMID: 32861965 Free PMC article. Review. References Sohrabi C, Alsafi Z, O’Neill N, et al.. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020; 76: 71–76. - - Sanders JM, Monogue ML, Jodlowski TZ, et al.. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA 2020; 323: 1824–1836. - Huang C, Wang Y, Li X, et al (...) .. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506. - - Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 2020; 8: e21. - - Grech V. Unknown unknowns – COVID-19 and potential global mortality. Early Hum Dev 2020; 144: 105026. - - Show all 41 references Publication types Meta-Analysis Actions Systematic Review Actions MeSH terms Antiviral Agents

2021 EvidenceUpdates

59. Multicenter evaluation of the Panbio COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection Full Text available with Trip Pro

lugar de asistencia al paciente. Procedimientos en Microbiología Clínica. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC) 2019. Available from: Nguyen T., Duong Bang D., Wolff A. 2019 Novel coronavirus disease (COVID-19): paving the road for rapid detection and point-of-care diagnostics. Micromachines (Basel) 2020;11:306. doi: 10.3390/mi11030306. - - - McHugh M.L. Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 2012;22:276–282. - - Show all 16 (...) Multicenter evaluation of the Panbio COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info Close

2021 EvidenceUpdates

60. Predictors of in-hospital mortality AND death RISK STRATIFICATION among COVID-19 PATIENTS aged >/= 80 YEARs OLD Full Text available with Trip Pro

Predictors of in-hospital mortality AND death RISK STRATIFICATION among COVID-19 PATIENTS aged >/= 80 YEARs OLD Predictors of in-hospital mortality AND death RISK STRATIFICATION among COVID-19 PATIENTS aged ≥ 80 YEARs OLD - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info Close Account Logged (...) Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Arch Gerontol Geriatr Actions . 2021 Feb 25;95:104383. doi: 10.1016/j.archger.2021.104383. Online ahead of print. Predictors of in-hospital mortality AND death RISK STRATIFICATION among COVID-19 PATIENTS aged ≥ 80 YEARs OLD , , , , , , , , , , Affiliations Expand Affiliations 1 Emergency Department - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore

2021 EvidenceUpdates